LIPIDRESCUE
LIVE

Serial Number

97492223

Owner

ResQ Pharma, Inc.

Attorney

Hillary Maynard

Filing Date

Jul 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

LIPIDRESCUE Trademark

Serial Number: 97492223

LIPIDRESCUE is a trademark filed by ResQ Pharma, Inc. on July 7, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

ResQ Pharma, Inc. (4 trademarks)

242 W. Harrison St., Suite 201
Chicago, IL 60612

Entity Type: 03

Trademark Details

Filing Date

July 7, 2022

Registration Date

Not Registered

Published for Opposition

August 29, 2023

Goods & Services

Medical services, namely, treating anesthetic toxicity, treating drug overdoses and poisoning, resuscitating patients suffering from the toxic side effects caused by anesthetics and unknown substances, treating cardiac toxins, administering lipid emulsions and other lipid containing substances to patients, and administering lipid emulsions to treat cardiac arrest due to ischemia, cardiac failure, and cardiac toxicity

Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe for administering the lipid emulsion, all for use in treating anesthetic and drug toxicity; Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe for administering the lipid emulsion, all for use in resuscitating patients; Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe for administering the lipid emulsion, all for use in treating cardiac arrest due to ischemia and cardiac failure; syringes that are used for administering lipid emulsions in the nature of syringes sold filled with a pharmaceutical, namely, a lipid emulsion for use in treating anesthetic and drug toxicity, treating neurological toxicity, treating cardiac arrest due to ischemia, treating cardiac failure, treating cardiac toxicity, and for resuscitating patients

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 18, 2026 EXRA
SOU EXTENSION 5 GRANTED
Jun 18, 2026 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 17, 2026 AITU
SOU TEAS EXTENSION RECEIVED
Jan 29, 2026 EEXT
SOU EXTENSION 5 FILED
Jan 28, 2026 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 4 GRANTED
Sep 5, 2025 EX4G
SOU EXTENSION 4 FILED
Sep 5, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 5, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 18, 2025 EXRA
SOU EXTENSION 3 GRANTED
Apr 17, 2025 EX3G
SOU EXTENSION 3 FILED
Apr 17, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 17, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 17, 2024 EXRA
SOU EXTENSION 2 GRANTED
Oct 17, 2024 EX2G
SOU EXTENSION 2 FILED
Oct 17, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 17, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 23, 2024 EXRA
SOU EXTENSION 1 GRANTED
Mar 22, 2024 EX1G
SOU EXTENSION 1 FILED
Mar 22, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 22, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 24, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 29, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 29, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 9, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 26, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 26, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 26, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 26, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 26, 2023 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 20, 2023 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 19, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 23, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 22, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 22, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 10, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 10, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 10, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 27, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 26, 2022 NWOS
NEW APPLICATION ENTERED
Jul 11, 2022 NWAP